Issues associated with the case report entitled "hypertensive urgency associated with Xenadrine EFX use"

J Pharm Pract. 2011 Dec;24(6):577-9; author reply 580. doi: 10.1177/0897190011422606.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Obesity Agents / adverse effects*
  • Humans
  • Hypertension / chemically induced*

Substances

  • Anti-Obesity Agents